Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)-Reference-Cited by-同舟云学术

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)

Published:2019-05-06 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Koemans W. J.^ORCID,van der Kaaij R. T.,Boot H.,Buffart T.,Veenhof A. A. F. A.,Hartemink K. J.,Grootscholten C.,Snaebjornsson P.,Retel V. P.,van Tinteren H.,Vanhoutvin S.,van der Noort V.,Houwink A.,Hahn C.,Huitema A. D. R.,Lahaye M.,Los M.,van den Barselaar P.,Imhof O.,Aalbers A.,van Dam G. M.,van Etten B.,Wijnhoven B. P. L.,Luyer M. D. P.,Boerma D.,van Sandick J. W.

Funder

ZonMw

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5640-2.pdf

Reference34 articles.

1. Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, Lemmens VE, de Hingh IH. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134(3):622–8.

2. Thomassen I, Bernards N, van Gestel YR, Creemers G-J, Jacobs EM, Lemmens VE, de Hingh IH. Chemotherapy as palliative treatment for peritoneal carcinomatosis of gastric origin. Acta Oncol. 2014;53(3):429–32.

3. Klaver YL, Simkens LH, Lemmens VE, Koopman M, Teerenstra S, Bleichrodt RP, de Hingh IH, Punt CJ. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol. 2012;38(7):617–23.